Select Medical Holdings Co. (NYSE:SEM - Free Report) - Research analysts at Zacks Research issued their FY2027 earnings per share estimates for Select Medical in a report issued on Thursday, March 6th. Zacks Research analyst Z. Masood anticipates that the health services provider will post earnings per share of $1.87 for the year. The consensus estimate for Select Medical's current full-year earnings is $1.17 per share.
A number of other analysts also recently weighed in on the company. Royal Bank of Canada cut their target price on Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research report on Monday, February 24th. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. UBS Group dropped their target price on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research report on Friday, January 3rd. Finally, Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target for the company in a report on Monday, February 24th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Select Medical has a consensus rating of "Moderate Buy" and a consensus target price of $27.25.
Get Our Latest Stock Report on SEM
Select Medical Stock Performance
Shares of SEM traded down $0.42 during mid-day trading on Friday, hitting $16.99. 897,008 shares of the company's stock were exchanged, compared to its average volume of 736,896. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 10.29, a price-to-earnings-growth ratio of 0.64 and a beta of 1.56. The stock's 50-day simple moving average is $18.91 and its 200-day simple moving average is $26.75. Select Medical has a 52 week low of $16.20 and a 52 week high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion.
Select Medical Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Investors of record on Monday, March 3rd will be issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 1.47%. The ex-dividend date is Monday, March 3rd. Select Medical's dividend payout ratio (DPR) is 15.15%.
Institutional Investors Weigh In On Select Medical
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Quarry LP acquired a new stake in shares of Select Medical during the third quarter valued at about $30,000. Smartleaf Asset Management LLC raised its position in shares of Select Medical by 179.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after acquiring an additional 1,473 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Select Medical in the third quarter worth approximately $81,000. Covestor Ltd boosted its holdings in Select Medical by 33.5% in the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock valued at $93,000 after acquiring an additional 1,244 shares during the last quarter. Finally, Lazard Asset Management LLC increased its position in Select Medical by 47.8% during the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after purchasing an additional 2,255 shares during the period. Institutional investors own 89.48% of the company's stock.
Select Medical Company Profile
(
Get Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
See Also

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.